Median Technologies SA
PAR:ALMDT

Watchlist Manager
Median Technologies SA Logo
Median Technologies SA
PAR:ALMDT
Watchlist
Price: 3.09 EUR -2.22% Market Closed
Market Cap: 113.5m EUR

During the last 3 months Median Technologies SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 12% over this period (open performance analysis).

The last transaction was made on Oct 21, 2023 by Thomas Bonnefont , who bought 66.8k EUR worth of ALMDT shares.

Last Transactions:
Thomas Bonnefont
€+66.8k
View All Transactions

During the last 3 months Median Technologies SA insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 12% over this period (open performance analysis).

The last transaction was made on Oct 21, 2023 by Thomas Bonnefont , who bought 66.8k EUR worth of ALMDT shares.

Sold
0-3
months
0 EUR
0
3-6
months
0 EUR
0
6-9
months
0 EUR
0
9-12
months
0 EUR
0
Bought
0-3
months
No Insider Transactions
0
0 EUR
3-6
months
No Insider Transactions
0
0 EUR
6-9
months
No Insider Transactions
0
0 EUR
9-12
months
No Insider Transactions
0
0 EUR

Median Technologies SA
Insider Trading Chart

Median Technologies SA
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Median Technologies SA
Last Insider Transactions

Global
Insiders Monitor

Median Technologies SA
Glance View

Market Cap
113.5m EUR
Industry
Health Care

MEDIAN Technologies SA engages in the development and market of software publishing solutions and provision of services in the field of medical imaging in oncology. The company is headquartered in Valbonne, Paca. The company went IPO on 2011-05-20. The firm develops lesion management solutions (LMS) to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review. The LMS line includes such products as LMS-Lung, a clinical application for the detection, evaluation and follow-up of lesions identified in CT images covering the chest; LMS-Track, a clinical application for the follow-up of oncology patients; and LMS-Liver, a clinical application for the initial evaluation and the follow-up of liver metastases and any other lesions identified in CT images covering the liver. The firm operates one subsidiary, Median Technologies Inc, based in the United States.

ALMDT Intrinsic Value
2.63 EUR
Overvaluation 15%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top